Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS
Contenido archivado el 2024-05-29

Dissecting the molecular pathways of brain dysfunction in myotonic dystrophy

Objetivo

Myotonic dystrophy (DM) is a complex, autosomal dominant, multisystemic disease, with an unusual pathogenic mechanism. A growing body of evidence supports a trans-dominant pathological effect of toxic RNA transcripts containing expanded CUG repeats in DM t ype 1 (DM1), and CCUG repeats in DM type 2 (DM2). Involvement of the central nervous system (CNS) in DM has been widely reported, with variable degrees of mental dysfunction particularly associated with DM1. However, it is not understood whether RNA-mediat ed disease pathways are responsible for the brain-specific disease manifestations. In order to investigate the DNA dynamics and the molecular pathology underlying this condition, transgenic mouse models carrying long CTG repeat tracts were generated. These animals not only recreate disease-associated DNA instability, but also DM1 muscle and brain abnormalities. By uniquely exhibiting a brain phenotype, this model provides a distinctive and powerful tool to investigate the far-reaching molecular, physiologic al and phenotypic consequences of the trans-acting pathogenic DM1 repeat expansion in the CNS. Imaging, histological, proteomic and electrophysiological techniques will be combined in a multidisciplinary project to functionally characterise DM1 mental dysf unction, and to identify target genes affected by the toxic repeat. The data will reveal alterations at the molecular and cellular level, as well as at the higher hierarchical level of the brain network, providing important insight into the molecular neuro pathogenesis of this disease. Findings will contribute to the dissection of fundamental neuronal pathways, with predicted implications to the understanding of disease- and ageing-associated neurodegeneration, promoting the advance of this complex and fasci nating area of research within the European Community. In the long-term, the results emerging from this study will establish a solid basis for the rational design of therapeutic interventions.

Ámbito científico (EuroSciVoc)

Palabras clave

Tema(s)

Convocatoria de propuestas

FP6-2002-MOBILITY-5
Consulte otros proyectos de esta convocatoria

Régimen de financiación

EIF - Marie Curie actions-Intra-European Fellowships

Coordinador

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICAL
Aportación de la UE
Sin datos
Coste total
Sin datos